Sort
8,912 grants matching “sars cov 2”
Identification, structures and ontogenies of SARS-CoV-2 antibodies
$245,592Tongqing Zhou · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Core-001
$245,552William W. Kwok · Benaroya Research Inst At Virginia Mason · U19 · FY2021 · AI
Task C1: A Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose Phase 1 Study of SARS-CoV-2 Therapeutics
$245,549Casey Long · Dynport Vaccine Company, Llc · N01 · FY2024 · AI
Development of Mucosal and Systemic Immunity and Risk of Food Allergy
$245,245Kirsi Jarvinen-Seppo · University Of Rochester · U01 · FY2021 · AI
Telemedicine and health disparities among community-dwelling older adults with ADRD during COVID-19 pandemic
$244,999Shubing Cai · University Of Rochester · R01 · FY2024 · AG
Characterizing the Immune Response to COVID-19 Infection in Atopic Dermatitis
$244,936Emma Guttman · Icahn School Of Medicine At Mount Sinai · U01 · FY2020 · AI
Investigation of Dpp9 in COVID19
$244,919Richard A Flavell · Yale University · R21 · FY2023 · AI
Development of a rapid multiplex CRISPR-based testing pathway for tuberculosis and COVID-19
$244,866Yingda Linda Xie · Rbhs-New Jersey Medical School · R21 · FY2022 · AI
Development of a Novel rAAV Vector Without Cross-species Barrier to Transduce Human and Ferret Conducting Airways
$244,800Jianming Qiu · University Of Kansas Medical Center · R21 · FY2021 · AI
Impacts of Adaptive Coronavirus Evolution on Viral Membrane Fusion
$244,800Thomas Miller Gallagher · Loyola University Chicago · R21 · FY2023 · AI
Characterizing the Immune Response to COVID-19 Infection in Atopic Dermatitis
$244,597Emma Guttman · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · AI
Core-002
$244,509Donna L Farber · Columbia University Health Sciences · U19 · FY2025 · AI
Roles of human surfactant collectin variants in the susceptibility of COVID-19
$244,500Guirong Wang · Upstate Medical University · R21 · FY2022 · AI
CRISPR-based editing of RNA and cellular mechanisms that govern RNA repair
$244,268Artem Aleksandrovich Nemudryi · University Of Florida · R00 · FY2025 · AI
Combined pathogen and host-based diagnostic to identify etiology of lower respiratory tract infection
$244,044Gayani Tillekeratne · Duke University · R21 · FY2025 · AI
Neurotropic Viral Infection in CNS Aging and Alzheimer's Disease COVID-19 Supplement
$243,918Kristen Emily Funk · University Of North Carolina Charlotte · R00 · FY2020 · AG
Epidemiology and Biosocial risk factors for adverse outcomes of COVID-19 in people with sickle cell disease : Analyses of national COVID surveillance registry
$243,880Anjali Alatkar Sharathkumar · University Of Iowa · R21 · FY2024 · MD
Clinical Phenotyping and Human Core
$243,834Richard G Wunderink · Northwestern University At Chicago · P01 · FY2022 · HL
IMMUNOGENIC SUGAR MOIETIES OF HCMV
$243,767Denong Wang · Sri International · R21 · FY2018 · AI
Collaborative Research: Environmental Fate and Impacts of Quaternary Ammonium Compounds Following Increased Use During the SARS-CoV‑2 Pandemic
$243,762William A Arnold · University Of Minnesota-Twin Cities · · FY2021 · ENG
The role of senescence in severe COVID-19
$243,750Tobias D. Raabe · University Of Pennsylvania · R21 · FY2024 · AI
The Oropharyngeal Microbiome in COVID-19
$243,750Ronald G Collman · University Of Pennsylvania · R21 · FY2024 · DE
Comprehensive analysis of epistasis in drug resistance potential of Mpro from SARS-CoV-2
$243,713Daniel N Bolon · Univ Of Massachusetts Med Sch Worcester · R21 · FY2025 · AI
Mechanisms of SARS-CoV2 translation initiation and shut-off of cellular protein synthesis
$243,563Christopher Ulrich Tristram Hellen · Suny Downstate Medical Center · R21 · FY2023 · AI
Anti-viral Active Air-Purifying Respirator with Photocatalytic Microreactor to Prevent Airborne Diseases
$243,500Arif Rahman · Hawai'I Innovation Laboratory, Inc. · R43 · FY2022 · OH